Table 1.
Characteristics | Total no of patients, n=86 | No of patients
|
P-value | |
---|---|---|---|---|
miR-92a high | miR-92a low | |||
Age (years) | ||||
≤45 | 42 | 20 | 22 | 0.666 |
>45 | 44 | 23 | 21 | |
Sex | ||||
Male | 63 | 30 | 33 | 0.465 |
Female | 23 | 13 | 10 | |
WHO type | ||||
I+II | 9 | 3 | 6 | 0.483 |
III | 77 | 40 | 37 | |
TNM stage | ||||
I+II | 28 | 8 | 20 | 0.006* |
III+IV | 58 | 35 | 23 | |
Distant metastasis | ||||
No | 68 | 29 | 39 | 0.008* |
Yes | 18 | 14 | 4 |
Note:
Statistically significant.
Abbreviations: miR-92a, microRNA-92a; NPC, nasopharyngeal carcinoma; TNM, tumor-node-metastasis; WHO, World Health Organization.